20 VCU Engineering faculty among world’s most-cited researchers in 2021, according to Stanford University study
VCU Engineering faculty are among the world's most-cited researchers.
Unfolding history: VCU students contribute to massive Holocaust research project
VCU Engineering staff member and history graduate student Kendall Sargent is contributing research to a U.S. Holocaust Memorial Museum project seeking to better understand what Americans knew about the Holocaust from reading local newspapers.
Bennett Ward, Ph.D., inducted into elite body of U.S. inventors
Bennett C. Ward, Ph.D., has invented the technologies behind a world of products including surgical devices, inkjet printers, at-home pregnancy tests and air fresheners.
VCU Commercialization Fund awards support to four VCU Engineering innovators
VCU Engineering leads the university in the latest round of VCU Commercialization Fund awards, receiving four of the six awards given.
B. Frank Gupton, Ph.D., discusses a redesign of pharmaceutical manufacturing
Sharon Bowes, anchor and producer of NewsPoint360, interviews B. Frank Gupton, Ph.D., CEO of VCU Engineering’s Medicines for All Institute, co-founder of Phlow Corp. and the college’s Floyd D. Gottwald, Jr. Chair in pharmaceutical engineering.
Research right now
A glance at some of the latest research projects at VCU, including VCU Engineering projects to improve air quality, save coral populations and expand availability of a potential COVID drug.
VCU’s Medicines for All Institute drives down production costs of molnupiravir, the first investigational pill to treat COVID-19
The Medicines for All Institute (M4ALL) in the Virginia Commonwealth University College of Engineering has developed low-cost manufacturing processes for molnupiravir, the first investigational pill to treat COVID-19.
U.S. Rep. Abigail Spanberger announces pharmaceutical readiness legislation at VCU’s College of Engineering
U.S. Rep. Abigail Spanberger spoke at the VCU College of Engineering to announce the introduction of legislation to create a strategic national stockpile of key ingredients used in essential generic medicines and to incentivize domestic manufacturing of these ingredients.
Disabling COVID’s ‘key’
As COVID-19 mutates to become more contagious, Michael Peters, Ph.D., is accelerating efforts to disable the “spikes” that give the coronavirus particle its familiar shape — and its power to prey on cells.
Navigating the nanoscale
For more than a decade, VCU’s Nanomaterials Core Characterization Facility has been helping researchers navigate the nanoscale, a world that is almost indescribably small.
